These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8155390)
1. Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma. Dosquet C; Schaetz A; Faucher C; Lepage E; Wautier JL; Richard F; Cabane J Eur J Cancer; 1994; 30A(2):162-7. PubMed ID: 8155390 [TBL] [Abstract][Full Text] [Related]
2. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma? Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646 [TBL] [Abstract][Full Text] [Related]
3. TNF alpha, IL-1 beta and IL-6 plasma levels in neutropenic patients after onset of fever and correlation with the C-reactive protein (CRP) kinetic values. Herrmann JL; Blanchard H; Brunengo P; Lagrange PH Infection; 1994; 22(5):309-15. PubMed ID: 7531179 [TBL] [Abstract][Full Text] [Related]
4. TNF alpha, IL-1 beta and IL-6 production by peripheral blood monocytes in patients with renal cell carcinoma. Ikemoto S; Sugimura K; Yoshida N; Wada S; Yamamoto K; Kishimoto T Anticancer Res; 2000; 20(1A):317-21. PubMed ID: 10769674 [TBL] [Abstract][Full Text] [Related]
5. Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia. Engel A; Kern WV; Mürdter G; Kern P Infection; 1994; 22(3):160-4. PubMed ID: 7927810 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of tumor necrosis factor-alpha, interleukin-1, and interleukin-6 in hemorrhagic fever with renal syndrome. Krakauer T; Leduc JW; Krakauer H Viral Immunol; 1995; 8(2):75-9. PubMed ID: 8825292 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of serum immunosuppressive acidic protein for staging renal cell carcinoma: comparison with other tumour markers. Masuda H; Kurita Y; Suzuki K; Fujita K; Aso Y Br J Urol; 1997 Jul; 80(1):25-9. PubMed ID: 9240175 [TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 plasma levels in neonatal sepsis. de Bont ES; Martens A; van Raan J; Samson G; Fetter WP; Okken A; de Leij LH Pediatr Res; 1993 Apr; 33(4 Pt 1):380-3. PubMed ID: 8479819 [TBL] [Abstract][Full Text] [Related]
9. [Serum levels and gene expressions of interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in human renal cell carcinomas]. Hamao T; Kanayama H; Kan M; Takigawa H; Kagawa S Nihon Hinyokika Gakkai Zasshi; 1994 Apr; 85(4):563-70. PubMed ID: 8189655 [TBL] [Abstract][Full Text] [Related]
10. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. Cannon JG; Tompkins RG; Gelfand JA; Michie HR; Stanford GG; van der Meer JW; Endres S; Lonnemann G; Corsetti J; Chernow B J Infect Dis; 1990 Jan; 161(1):79-84. PubMed ID: 2295861 [TBL] [Abstract][Full Text] [Related]
11. Prognostic role of interleukin-6 in renal cell carcinoma: a meta-analysis. Wang Y; Zhang Y Clin Transl Oncol; 2020 Jun; 22(6):835-843. PubMed ID: 31410730 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma. Naglieri E; Lopez M; Lelli G; Morelli F; Amodio A; Di Tonno P; Gebbia N; Di Seri M; Chetri MC; Rizzo P; Abbate I; Casamassima A; Selvaggi FP; Colucci G Anticancer Res; 2002; 22(5):3045-51. PubMed ID: 12530040 [TBL] [Abstract][Full Text] [Related]
13. [Significance of plasma interleukin-6 in the diagnosis of renal cell carcinoma]. Kamemoto H Hinyokika Kiyo; 1993 Apr; 39(4):301-6. PubMed ID: 8503325 [TBL] [Abstract][Full Text] [Related]
14. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels. Horstmann M; Merseburger AS; von der Heyde E; Serth J; Wegener G; Mengel M; Feil G; Hennenlotter J; Nagele U; Anastasiadis A; Bokemeyer C; Stenzl A; Kuczyk M J Cancer Res Clin Oncol; 2005 Nov; 131(11):715-22. PubMed ID: 16080018 [TBL] [Abstract][Full Text] [Related]
15. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study. Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502 [TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 levels in febrile, young children with and without occult bacteremia. Strait RT; Kelly KJ; Kurup VP Pediatrics; 1999 Dec; 104(6):1321-6. PubMed ID: 10585983 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokine responses in juvenile chronic arthritis. Rooney M; David J; Symons J; Di Giovine F; Varsani H; Woo P Br J Rheumatol; 1995 May; 34(5):454-60. PubMed ID: 7788176 [TBL] [Abstract][Full Text] [Related]
18. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Casey LC; Balk RA; Bone RC Ann Intern Med; 1993 Oct; 119(8):771-8. PubMed ID: 8379598 [TBL] [Abstract][Full Text] [Related]
19. Endotoxaemia and inflammatory mediators in febrile patients with haematological disease. Günther G; Gårdlund B; Hast R; Kimby E; Nordin M; Wretlind B J Intern Med; 1995 Jan; 237(1):27-33. PubMed ID: 7830027 [TBL] [Abstract][Full Text] [Related]
20. [Cytokines value as a sepsis and mortality predictor in elderly patients with fever]. Martí L; Moreno A; Filella X; Marín JL; Almela M; Benito N; Sánchez M; Gatell JM Med Clin (Barc); 2003 Sep; 121(10):361-6. PubMed ID: 14565910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]